Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Marijuana Abuse 2Tourette Syndrome 1Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1Parkinson Disease 1Pancreatic Cancer Non-resectable 1Pain 1Opioid-Related Disorders 1Neoplasms 1Multiple Sclerosis 1Marijuana Use 1Inflammatory Bowel Diseases 1Hepatitis C 1Glaucoma 1Fibromyalgia 1Epilepsy 1Depression 1Crohn Disease 1Coronavirus Infections 1Colitis, Ulcerative 1Chronic Traumatic Encephalopathy 1Chronic Pain 1Carcinoma, Hepatocellular 1COVID-19 1Brain Injuries, Traumatic 1Bipolar Disorder 1Autistic Disorder 1Anxiety Disorders 1

Interventions

drospirenone 1Venlafaxine Hydrochloride 1Saline Solution 1Metformin 1Medical Marijuana 1Infliximab 1Gabapentin 1Exercise 1Ethinyl Estradiol 1Contraceptives, Oral, Combined 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bipolar Disorder × Medical Marijuana × Clear all
NCT03944447 2022-06-02

OMNI-Can

OMNI Medical Services, LLC

Phase 2 Unknown
200,000 enrolled
Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡